TIBELLA

biosyent pharma inc🇨🇦 Health Canada

Approval Id: 03280d3990f5d67c
Drug Approval Canada Name: TIBELLA
Product Name: TIBELLA
Status: Marketed
Status Date: 2020-07-29
Original Market Date: 2020-07-29
Din: 02488361
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Schedule G (CDSA IV)
Ahfs: 68:16.00
Atc Original: G03CX01 TIBOLONE
Atc Name: g 03 cx 01
Aig Number: 0161430001
Company Name: biosyent pharma inc
Company Address: SUITE 402, 2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1

TIBOLONE

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

03280d3990f5d67c

Type

Standard